ONCO
Price
$0.14
Change
-$0.02 (-12.50%)
Updated
May 21, 10:23 AM (EDT)
83 days until earnings call
VERA
Price
$39.76
Change
-$1.23 (-3.00%)
Updated
May 21, 01:06 PM (EDT)
79 days until earnings call
Ad is loading...

ONCO vs VERA

Header iconONCO vs VERA Comparison
Open Charts ONCO vs VERABanner chart's image
Onconetix
Price$0.14
Change-$0.02 (-12.50%)
Volume$2.3K
CapitalizationN/A
Vera Therapeutics
Price$39.76
Change-$1.23 (-3.00%)
Volume$1.83K
CapitalizationN/A
View a ticker or compare two or three
ONCO vs VERA Comparison Chart

Loading...

ONCODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VERADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ONCO vs. VERA commentary
May 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONCO is a Hold and VERA is a Hold.

COMPARISON
Comparison
May 21, 2024
Stock price -- (ONCO: $0.16 vs. VERA: $41.39)
Brand notoriety: ONCO and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ONCO: 2206% vs. VERA: 45%
Market capitalization -- ONCO: $3.48M vs. VERA: $2.24B
ONCO [@Biotechnology] is valued at $3.48M. VERA’s [@Biotechnology] market capitalization is $2.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ONCO’s FA Score shows that 1 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • ONCO’s FA Score: 1 green, 4 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, both ONCO and VERA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ONCO’s TA Score shows that 4 TA indicator(s) are bullish while VERA’s TA Score has 3 bullish TA indicator(s).

  • ONCO’s TA Score: 4 bullish, 4 bearish.
  • VERA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ONCO is a better buy in the short-term than VERA.

Price Growth

ONCO (@Biotechnology) experienced а +47.17% price change this week, while VERA (@Biotechnology) price change was +0.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.66%. For the same industry, the average monthly price growth was +6.20%, and the average quarterly price growth was +62.87%.

Reported Earning Dates

ONCO is expected to report earnings on Aug 12, 2024.

VERA is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (+1.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ONCO with price predictions.
OPEN
A.I.dvisor published
a Summary for VERA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VERA($2.24B) has a higher market cap than ONCO($3.48M). VERA YTD gains are higher at: 169.116 vs. ONCO (-21.212).
ONCOVERAONCO / VERA
Capitalization3.48M2.24B0%
EBITDAN/AN/A-
Gain YTD-21.212169.116-13%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
ONCOVERA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 7 days ago
88%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
ONCODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VERADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASNS0.520.01
+1.96%
Actelis Networks
HNI45.98-0.28
-0.61%
HNI Corp
NCLH15.75-0.14
-0.88%
Norwegian Cruise Line Holdings Ltd
SILC16.50-0.30
-1.79%
Silicom Ltd
OABI4.45-0.10
-2.20%
OmniAb

ONCO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONCO has been loosely correlated with INO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCO jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCO
1D Price
Change %
ONCO100%
+10.64%
INO - ONCO
50%
Loosely correlated
-6.18%
PCSA - ONCO
44%
Loosely correlated
-2.00%
VERA - ONCO
36%
Loosely correlated
-1.31%
NGM - ONCO
34%
Loosely correlated
N/A
OCS - ONCO
26%
Poorly correlated
+0.04%
More